Oviedo Medical Research

Executive Summary

Oviedo Medical Research is a privately-held clinical research organization (CRO) based in Oviedo, Florida, specializing in Phase II through IV clinical trials. Founded in 2010, the company focuses on therapeutic areas such as diabetes, obesity, and metabolic health, partnering with pharmaceutical and biotech firms to manage and execute studies. Operating a dedicated research center, it facilitates patient participation and study management. As a small, private CRO, Oviedo Medical Research benefits from the growing demand for outsourced clinical trials driven by drug development pipelines. Its regional presence in Florida positions it to engage a diverse patient population, though it faces competition from larger global CROs. The company's growth is tied to securing new trial contracts and expanding its therapeutic expertise.

Upcoming Catalysts (preview)

• Q4 2026Major New Trial Contract with Top Pharma40% success
• Q2 2027Expansion into New Therapeutic Area (e.g., cardiovascular)30% success
• Q1 2027Completion of Key Diabetes Study with Positive Results60% success